Category: Corporate NewsBy Rameda AdminMay 28, 2024 Author: Rameda Admin Post navigationPreviousPrevious post:BOD-Shareholding-Structure-2024NextNext post:Rameda Announces Price Increase Approvals for All Its Top ProductsRelated PostsEarning Release One Pager 2Q24August 13, 2024Rameda Announces Price Increase Approvals for All Its Top ProductsAugust 7, 2024Rameda 4Q23 Earnings ReleaseMarch 20, 2024Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic PortfolioNovember 28, 2023Rameda Reports its 3Q23 ResultsNovember 14, 2023Equinox Pharma Holding Limited (Equinox) increases stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.November 6, 2023
Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic PortfolioNovember 28, 2023
Equinox Pharma Holding Limited (Equinox) increases stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.November 6, 2023